R&D Systems™ Human LRP-6 Fc Chimera Recombinant Protein

Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Binding Activity

Manufacturer:  R&D Systems™ 1505LR025

Catalog No. 1505LR025

Description

The Recombinant Human LRP-6 Fc Chimera Protein is derived from NS0. The Recombinant Human LRP-6 Fc Chimera Protein has been validated for the following applications: Binding Activity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in PBS.
• Molecular Weight: 180 kDa (monomer)
• Purity: 80%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Source: Mouse myeloma cell line,NS0-derived human LRP-6 protein, (N-terminus) Human LRP-6 (Ala20-Pro1368) Accession &Num; O75581 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Structural Form: Disulfide-linked homodimer
• Conjugate: Unconjugated

• Gene ID (Entrez): 4040
• Name: LRP-6 Fc Chimera
• Quantity: 25μg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.1 EU per 1μg of the protein by the LAL method.
• Recombinant: Yes